Overview

Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor

Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the outcome of intracranial non-germinomatous germ cell tumor (NGGCT) treated with reduced radiotherapy following high dose chemotherapy and autologous stem cell transplantation (HDCT/auto-SCT).
Phase:
Phase 2
Details
Lead Sponsor:
Samsung Medical Center
Treatments:
Bleomycin
Carboplatin
Cyclophosphamide
Etoposide
Etoposide phosphate
Melphalan
Thiotepa